chrisvoncsefalvay/vaers-outcomes huggingface dataset:
feeling draggy; shaking; 102.4 fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEELING ABNORMAL (feeling draggy), TREMOR (shaking) and PYREXIA (102.4 fever) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included PARACETAMOL (TYLENOL), CARVEDILOL, DULOXETINE HYDROCHLORIDE (DULOXETINE [DULOXETINE HYDROCHLORIDE]), ASA, NICOTINAMIDE (VIT B3), CYANOCOBALAMIN (B12-VITAMIN), FISH OIL (OMEGA 3 [FISH OIL]), ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]), ASCORBIC ACID (VIT C 25 FRX), ATORVASTATIN and DENOSUMAB (PROLIA).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced FEELING ABNORMAL (feeling draggy), TREMOR (shaking) and PYREXIA (102.4 fever). At the time of the report, FEELING ABNORMAL (feeling draggy), TREMOR (shaking) and PYREXIA (102.4 fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, Body temperature: 102.4 (High) high fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment Tylenol 600mg  was provided.   Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Chest heaviness/ tightness during working hours of 12 noon-12 midnight.  No treatment that night.  No treatment.  Follow-up as necessary.
A couple of hours after receiving an injectable Flu vaccine the patient developed abdominal pain followed by episodes of vomiting and upward rolling of eyeballs and shaking of his extremities while at the grocery store with his mother. He was taken via EMS to Medical Center where he was kept for observation. According to the ER report was post ictal for 3-4 hours.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' pertinent medical history, concomitant medications and drug reactions or allergies reported. On unknown dates, the patients were vaccinated with improperly stored doses of (Oka/Merck) VARIVAX injection, lot # L042266, expiration date 27-OCT-2017 (dose, anatomical location and route of administration were not specified). No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
Developed a rash on both forearms 2 hrs. after the vaccine while at home. over the course of the next three days it spread to my chest, underarms, lower back, inside both thighs, and lower kegs.  Large welts developed in those areas.  I contacted a covid nurse and she called me and advised over the counter Benadryl for symptoms and to contact my doctor. I messaged him and sent photos of the infected areas. He prescribed Prednisone 10 mg to take in a five day burst.  It has been two weeks now and this rash is just now getting better. I wonder if a second dose is advisable.
Felt bad; Night sweats; Ear ache on left side that radiated down to shoulder; Sinus congestion; weak legs; Weak; Blurred vision; dizziness; Lymph node on left side of throat was swollen; Tired; Ear ache on left side that radiated down to shoulder; Continuing Fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt bad), NIGHT SWEATS (Night sweats), EAR PAIN (Ear ache on left side that radiated down to shoulder), SINUS CONGESTION (Sinus congestion) and PAIN IN EXTREMITY (weak legs) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 007A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Felt bad), NIGHT SWEATS (Night sweats), EAR PAIN (Ear ache on left side that radiated down to shoulder), SINUS CONGESTION (Sinus congestion), PAIN IN EXTREMITY (weak legs), ASTHENIA (Weak), VISION BLURRED (Blurred vision), DIZZINESS (dizziness), LYMPHADENOPATHY (Lymph node on left side of throat was swollen), FATIGUE (Tired), ARTHRALGIA (Ear ache on left side that radiated down to shoulder) and PYREXIA (Continuing Fever). The patient was treated with AMOXICILLIN at a dose of 1 dosage form. At the time of the report, FEELING ABNORMAL (Felt bad), NIGHT SWEATS (Night sweats), EAR PAIN (Ear ache on left side that radiated down to shoulder), SINUS CONGESTION (Sinus congestion), PAIN IN EXTREMITY (weak legs), ASTHENIA (Weak), VISION BLURRED (Blurred vision), DIZZINESS (dizziness), LYMPHADENOPATHY (Lymph node on left side of throat was swollen), FATIGUE (Tired), ARTHRALGIA (Ear ache on left side that radiated down to shoulder) and PYREXIA (Continuing Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Jan-2021, SARS-CoV-1 test: positive (Positive) Positive.         Treatment medication included steroid shot and pain medicine.   This case was linked to MOD-2021-142164 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: follow up received and it contains information about laboratory information and events were updated.
according to patient, patient had ear pain and jaw pain. pain level 7 out of 10. and it is getting better
Feet, legs, calves swelling; Breast hurt; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Feet, legs, calves swelling) and BREAST PAIN (Breast hurt) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, the patient experienced PERIPHERAL SWELLING (Feet, legs, calves swelling) and BREAST PAIN (Breast hurt). At the time of the report, PERIPHERAL SWELLING (Feet, legs, calves swelling) and BREAST PAIN (Breast hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Products known to have been used by the patient, within two weeks prior to the event, included eye vitamin.  Patient is taking Lasix PRN for swelling but not helping much.
This is a spontaneous report from a non-contactable consumer via a sales representative. A female patient of an unspecified age received BNT162B2 (COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as 1st dose in arm, single dose for covid-19 immunisation. The patient medical history and concomitant medication were not reported. The patient experienced the arm that she received the shot on felt tingly and weak for a few days on an unspecified date. Outcome of the events were recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 29-NOV-2013, the patient was vaccinated with the first dose of GARDASIL (dose, route of administration, lot # and expiration date were not reported). On 02-JUN-2015, the patient was vaccinated with the second dose of the series with GARDASIL 9 (dose, route of administration, lot # and expiration date were not reported). No adverse effects reported. Additional information has been requested.
Information has been received from a healthcare worker referring to 2 unspecified patients of unknown age and gender. On an unknown dates the patients were administered improperly stored dose of (Oka/Merck) VARIVAX (strength, lot#, dosage, frequency and route unspecified). No adverse effects was reported. Additional information has been requested.
Had vaccines at 9:30 am - when returned home at 10:00 am "it felt like something was stuck in my throat.  I couldn't swallow".  Client went to doctor at 3 pm.  Client was given Claritin qd.  Symptoms as of 4:30 pm on 10/25/07 hasn't worsen.
Redness developed at the injection; This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 58-year-old female patient who received Herpes zoster (Shingrix) (batch number N2E73, expiry date 19th March 2022) for prophylaxis.   On 26th August 2020, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced injection site erythema. On an unknown date, the outcome of the injection site erythema was unknown.   It was unknown if the reporter considered the injection site erythema to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and developed redness at the injection site and traveled down to the elbow area. The reporter consented to follow up.
This spontaneous report was received from a registered nurse referring to a 20 year old female patient. The patient's medical history and concurrent condition were not reported. On 17-JUL-2015, the patient was vaccinated with a pediatric dose of VAQTA 25/0.5 (Lot# L009445; expiration date: 01-JUN-2017) (dose and route of administration were not reported), in error. Concomitant medication was not reported. No adverse experience has been reported. There was not a product quality complaint involved. Additional information has been requested.
Left shoulder and arm pain started a few days after the shot and still not gone after almost half a year. The pain is bearable and I din't report to my doctor. I thought it might be helpful  to others if I report to CDC.
Chest pain persisted for ~3 day. Chest congestion for ~7 days with occassional heartburn-like pain. On 3/31/21, sharp pain in left arm and back.
Woke up next morning with erythema, swelling and itching near injection site.Returned to clinic 5/16/13, was seen by practitioner. Advised ice, Zyrtec and if needed Benadryl. Pt did not return for follow-up visit 5/17, reported area decreasing in size and less red.
ITCHING SENSATION ON LEFT FOOT VEIN (FEELING AS A PRICK); TACHYCARDIA; This spontaneous report received from a consumer concerned a 61 year old female. The patient's height and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin not reported, batch number: 1805031 and expiry: UNKNOWN) dose was not reported, 1 total, administered on 13-Mar-2021 on left arm for prophylactic vaccination. The patient experienced phlebitis when treated with first dose of covid-19 vaccine ad26.cov2.s.  The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: 211D21A and expiry: UNKNOWN) dose was not reported, 1 total, administered on 03-DEC-2021 on left arm for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date in DEC-2021, the patient experienced itching sensation on left foot vein where she got phlebitis after first dose (feeling as a prick) and tachycardia (Dose number in series was 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the itching sensation on left foot vein/ feeling as a prick and tachycardia was not reported. This report was non-serious. This case, involving the same patient is linked to 20211260960 (Dose number in series 1).
This spontaneous report as received from a nurse refers to a patient of unknown age. Patient medical history and current condition was not reported. On 05-JAN-2015 the patient was vaccinated with an expired dose of PNEUMOVAX 23 (dose reported as 0.5 ml via intramuscular route) (Lot # J004387 and expiry date 04-JAN-2015). No symptoms reported. The outcome of the event was unknown. Additional information has been requested.
Hair loss; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (Hair loss) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced ALOPECIA (Hair loss). At the time of the report, ALOPECIA (Hair loss) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported by reporter. No concomitant medications were reported by reporter.   Reporter did not allow further contact
Some bruising; Sore arm; Fever from 100-101; Diarrhea; Energy is not completely back; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Some bruising), DIARRHOEA (Diarrhea), ASTHENIA (Energy is not completely back), VACCINATION SITE PAIN (Sore arm) and PYREXIA (Fever from 100-101) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced CONTUSION (Some bruising) and VACCINATION SITE PAIN (Sore arm). In February 2021, the patient experienced DIARRHOEA (Diarrhea), ASTHENIA (Energy is not completely back) and PYREXIA (Fever from 100-101). On 09-Feb-2021, CONTUSION (Some bruising), DIARRHOEA (Diarrhea), VACCINATION SITE PAIN (Sore arm) and PYREXIA (Fever from 100-101) had resolved. At the time of the report, ASTHENIA (Energy is not completely back) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100-101 (High) Fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medication was reported. Treatment information for the events was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-028867 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-028867:husband case
At approximately 1310 client received Pfizer was ready to leave. She  asked her if she was feeling good. Client responded by stating that she felt numbness and tingling on her left arm as well as left side of torso, by stomach. Client denied shortness of breath, denied any itchiness, and stated she was able to swallow. Arm was assessed by nurse no redness, no swelling was observed on left arm of injection site. Client stated she had a rash on her stomach from previous days and had spoken to her provider. Vitals at 1320 HR 77 02 96% 1325 BP 116/90 HR 64 02 98%. At 1320 client stated she started feeling neck pain as well pain scale 3/10. At 1325 water was provided for client and had a few sips of water. Pt stated she had something to eat in the morning. Client stated her arm was feeling better and stated she has type 2 diabetes and took Metformin in the morning. Vitals at 1330 BP 128/84 HR 64 02 98% RR 18 Client stated she had regained feeling in her arm and neck pain was better. Pain scale 2/10.Vitals 1335 BP 124/90 HR 74 02 97 RR 16, at this time client denied having any neck pain, and stated she had less tingling and no tingling on her left side of stomach. Client was observed for 30mins for further assessment. client stated she felt comfortable going home and driving herself. Client was educated  about seeking emergency care if symptoms worsen. She was also recommended to follow up with her provider to inform about symptoms. She was offered a handout for VSafe. Client verbalized understanding. Client left vaccination site walking in a steady gait and was escorted to her car by  in no apparent distress.
Initial and follow up information has been received from a registered nurse concerning a 4 year old female with no known allergies who on 14NOV2003 was vaccinated with the second dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live, subcutaneous administration in the left upper arm. On the same day, the patient was vaccinated with poliovirus inactivated in the left arm, influenza virus vaccine in the right arm, and diphtheria toxoid + pertussis vaccine + tetanus toxoid in the right arm all administered intramuscularly. Immediately after vaccination with measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live, the patient developed a 3 to 4, 1-2 cm hives next to the injection vaccination site. The nurse reported that the poliovirus vaccine was administered on the left arm but at a different location. No treatment was required and the patient was monitored in the office. Within 15 minutes of the vaccination, the patient recovered from the hives. The nurse reported that the hives were self limited and not associated with any other therapies. Additional information is not expected.
skin is very scabby; it's spreading on entire left side of the body/leg is itching/back is itching/itching is on the inside of flesh; bad hives; swelling; little itchy/super duper itchy/scratched my arm to the point of bleeding; the day of injection my arm was really sore; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling), DRY SKIN (skin is very scabby), PRURITUS (it's spreading on entire left side of the body/leg is itching/back is itching/itching is on the inside of flesh), VACCINATION SITE PRURITUS (little itchy/super duper itchy/scratched my arm to the point of bleeding) and VACCINATION SITE PAIN (the day of injection my arm was really sore) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939902) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Aug-2021, the patient experienced SWELLING (swelling), VACCINATION SITE PRURITUS (little itchy/super duper itchy/scratched my arm to the point of bleeding) and VACCINATION SITE PAIN (the day of injection my arm was really sore). On 28-Aug-2021, the patient experienced DRY SKIN (skin is very scabby), PRURITUS (it's spreading on entire left side of the body/leg is itching/back is itching/itching is on the inside of flesh) and VACCINATION SITE URTICARIA (bad hives). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. On 28-Aug-2021, VACCINATION SITE PAIN (the day of injection my arm was really sore) had resolved. At the time of the report, SWELLING (swelling) was resolving, DRY SKIN (skin is very scabby), PRURITUS (it's spreading on entire left side of the body/leg is itching/back is itching/itching is on the inside of flesh) and VACCINATION SITE URTICARIA (bad hives) outcome was unknown and VACCINATION SITE PRURITUS (little itchy/super duper itchy/scratched my arm to the point of bleeding) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant drug details were reported.
Extreme dizziness, loss of balance, vertigo. Tingling in face and arm.
Tiredness and whole body muscle pain/aches that started a few days after vaccine and lasted for three days.
To ED with cough and congestion and dyspnea for several days.  Today he felt so weak that he fell out of bed an hour ago.  He denies any pain or injury from the fall.  He has tachypnea and fever upon arrival.  He has COPD history as former smoker normally wears home O2.  Found to be COVID positive. Acute on chronic respiratory failure with hypoxia  No dynamic changes and no acute ischemic changes on EKG. This is likely due to demand ischemia. Continue w/ conservative medical mgmt. Treated w/ heparin per ACS protocol. Continue w/ ASA, DVTP, supportive care. discharged and is scheduled for EMS pickup for subacute rehabilitation later this afternoon
Today I got it all over my back and I keep getting it every day; covid test result Positive; covid test result Positive; got rashes; hives; redness in different areas of my body; Booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 01Dec2021 19:00 (Lot number: FF2590) at the age of 31 years as dose 3 (booster), single for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The patient's relevant medical history was not reported. The patient did not have covid prior to vaccination and had not known allergies. There were no concomitant medications. Vaccination history included: Moderna (DOSE 2, Lot Number: 005C21A), administration date: 29Apr2021, when the patient was 31 years old, for Covid-19 immunization; Moderna (DOSE 1, Lot Number: 007B21A), administration date: 01Apr2021, when the patient was 31 years old, for Covid-19 immunization. The patient did not receive any other vaccine in four weeks. The patient did not receive other medications in two weeks. The following information was reported: IMMUNISATION (medically significant) with onset 01Dec2021 19:00, outcome "unknown", described as "Booster"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 13Dec2021, outcome "unknown" and all described as "covid test result Positive"; RASH (non-serious) with onset 01Dec2021 20:00, outcome "not recovered", described as "got rashes"; URTICARIA (non-serious) with onset 01Dec2021 20:00, outcome "not recovered", described as "hives"; ERYTHEMA (non-serious) with onset 01Dec2021 20:00, outcome "not recovered", described as "redness in different areas of my body"; CONDITION AGGRAVATED (non-serious) with onset 17Dec2021, outcome "not recovered", described as "Today I got it all over my back and I keep getting it every day". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (13Dec2021) positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of rash, urticaria, erythema, condition aggravated.  Clinical course: It was stated that immediately after the Pfizer booster shot had events. This had been going ever since. Today patient got it all over her back and patient keep getting it every day.  No follow-up attempts are possible. No further information is expected.